|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.690 SEK | +1.36% |
|
-4.35% | +17.68% |
| 07-23 | Mendus board member Sijmen de Vries makes a small share purchase | FW |
| 07-16 | Mendus prepares new CML study with Australian research institute | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 43.96M | - | ||||
| 48.22B | |||||
| 38.79B | - | - | - | - | - |
| 38.41B | |||||
| 34.88B | |||||
| 29.19B |
- Stock Market
- Stocks
- IMMU Stock
- Charts Mendus AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
